Olfson, M, Marcus, SC.
National patterns in antidepressant medication
treatment. Arch Gen Psychiatry
2009; 66: 848–56.
Exeter, D, Robinson, E, Wheeler, A.
Antidepressant dispensing trends in New Zealand between 2004
and 2007. Aust N Z J Psychiatry
2009; 43: 1131–40.
Deambrosis, P, Chinellato, A, Terrazzani, G, Pullia, G, Giusti, P, Skaper, SD, et al.
Antidepressant drug prescribing patterns to outpatients of an
Italian local health authority during the years 1998 to
2008. J Clin Psychopharmacol
2010; 30: 212–5.
Verdoux, H, Tournier, M, Begaud, B.
Antipsychotic prescribing trends: a review of
pharmaco-epidemiological studies. Acta Psychiatr
Castle, L, Aubert, RE, Verbrugge, RR, Khalid, M, Epstein, RS.
Trends in medication treatment for ADHD.
J Atten Disord
2007; 10: 335–42.
Knellwolf, AL, Deligne, J, Chiarotti, F, Auleley, GR, Palmieri, S, Boisgard, CB, et al.
Prevalence and patterns of methylphenidate use in French
children and adolescents. Eur J Clin
2008; 64: 311–7.
Prescription drugs debate continues on Capitol
Hill. Washington Times
2011; 21 July.
Prescription drugs and the changing patterns of treatment for
mental disorders, 1996–2001. Health Aff
IMS Institute for Healthcare Informatics. The Use
of Medicines in the United States: Review of 2010.
IMS Institute for Healthcare
Informatics, 2011 (http://www.imshealth.com/).
De Hert, M, Detraux, J, van Winkel, R, Yu, W, Correll, CU.
Metabolic and cardiovascular adverse effects associated with
antipsychotic drugs. Nat Rev Endocrinol
2011; Oct 18. Epub ahead of print.
Moret, C, Isaac, M, Briley, M.
Problems associated with long-term treatment with selective
serotonin reuptake inhibitors. J
2009; 23: 967–74.
NHS Information Centre for Health and Social Care.
Data Quality (Prescription Cost Analysis).
NHS Information Centre,
Joint Formulary Committee. British National
Formulary (62 edn). BMJ Group
and Pharmaceutical Press,
Ventriglio, A, Vincenti, A, Centorrino, F, Talamo, A, Fitzmaurice, G, Baldessarini, RJ.
Use of mood stabilizers for hospitalized psychotic and
bipolar disorder patients. Int Clin
Johannessen, LC, Larsson, PG, Rytter, E, Johannessen, SI.
Antiepileptic drugs in epilepsy and other disorders–a
population-based study of prescriptions. Epilepsy
2009; 87: 31–9.
Committee on the Safety of Medicines. Thiroidazine:
Restricted Indicationand New Warnings on Cardio-toxicity.
Committee on the Safety of Medicines,
Pillay, P, Moncrieff, J.
Contribution of psychiatric disorders to occupation of NHS
beds: analysis of Hospital Episode Statistics.
2011; 35: 56–9.
Arias, LH, Lobato, CT, Ortega, S, Velasco, A, Carvajal, A, del Pozo, JG.
Trends in the consumption of antidepressants in Castilla y
Leon (Spain). Association between suicide rates and antidepressant drug
consumption. Pharmacoepidemiol Drug Saf
Zahl, PH, De Leo, D, Ekeberg, O, Hjelmeland, H, Dieserud, G.
The relationship between sales of SSRI, TCA and suicide rates
in the Nordic countries. BMC Psychiatry
2010; 10: 62.
Alexander, GC, Gallagher, SA, Mascola, A, Moloney, RM, Stafford, RS.
Increasing off-label use of antipsychotic medications in the
United States, 1995–2008. Pharmacoepidemiol Drug
2011; 20: 177–84.
Moore, M, Yuen, HM, Dunn, N, Mullee, MA, Maskell, J, Kendrick, T.
Explaining the rise in antidepressant prescribing: a
descriptive study using the general practice research
Osborn, DP, Levy, G, Nazareth, I, Petersen, I, Islam, A, King, MB.
Relative risk of cardiovascular and cancer mortality in
people with severe mental illness from the United Kingdom's General
Practice Research Database. Arch Gen
2007; 64: 242–9.
Ornstein, S, Stuart, G, Jenkins, R.
Depression diagnoses and antidepressant use in primary care
practices: a study from the Practice Partner Research Network
(PPRNet). J Fam Pract
Lai, LL, Tan, MH, Lai, YC.
Prevalence and factors associated with off-label
antidepressant prescriptions for insomnia. Drug
Healthc Patient Saf
Freburger, JK, Holmes, GM, Agans, RP, Jackman, AM, Darter, JD, Wallace, AS, et al.
The rising prevalence of chronic low back
pain. Arch Intern Med
2009; 169: 251–8.
Kaye, JA, Bradbury, BD, Jick, H.
Changes in antipsychotic drug prescribing by general
practitioners in the United Kingdom from 1991 to 2000: a population-based
observational study. Br J Clin Pharmacol
2003; 56: 569–75.
Moreno, C, Laje, G, Blanco, C, Jiang, H, Schmidt, AB, Olfson, M.
National trends in the outpatient diagnosis and treatment of
bipolar disorder in youth. Arch Gen
2007; 64: 1032–9.
National Prescribing Centre. Benzodiazepines
and newer hypnotics. MeReC Bulletin